Cite
HARVARD Citation
Kim, Y. et al. (2019). Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials. HIV research & clinical practice. 20 (3), pp. 73-81. [Online].